Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,221
Out of 5,122 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $28.22 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $74.63 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $251.22 | +27.38% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $103.18 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $38.09 | +26.02% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $139.13 | - | 4 | Apr 16, 2019 | |
| HSDT Solana Company | Downgrades: Neutral | n/a | $2.33 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Holdings | Upgrades: Buy | $80 | $161.30 | -50.40% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $12.50 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $102.51 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $109.02 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $91.62 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $71.63 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $82.10 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $28.22
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $74.63
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $251.22
Upside: +27.38%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $103.18
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $38.09
Upside: +26.02%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $139.13
Upside: -
Solana Company
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $2.33
Upside: -
iRhythm Holdings
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $161.30
Upside: -50.40%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $12.50
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $102.51
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $109.02
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $91.62
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $71.63
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $82.10
Upside: -